Epilepsy in Wolf-Hirschhorn syndrome (4p-)

Epilepsia

Volumn 46, Issue 1, 2005, Pages 150-155

  Kagitani Shimono, Kuriko ^a,d   Imai, Katsumi ^a   Otani, Kazumasa ^b   Kamio, Noriko ^a   Okinaga, Takeshi ^a   Toribe, Yasuhisa ^c   Suzuki, Yasuhiro ^c   Ozono, Keiichi ^a  

^a OSAKA UNIVERSITY   (Japan)

^b Otani Clinic   (Japan)

^c RESEARCH INSTITUTE FOR MATERNAL AND CHILD HEALTH   (Japan)

^d OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Bromide; Status epilepticus; Wolf Hirschhorn syndrome

Indexed keywords

CLORAZEPATE; NITRAZEPAM; SODIUM BROMIDE;

ADOLESCENT; ADULT; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTRACHEAL INTUBATION; EPILEPTIC STATE; FEBRILE CONVULSION; FEMALE; FOCAL EPILEPSY; HUMAN; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RESPIRATORY FAILURE; REVIEW; TONIC CLONIC SEIZURE; TONIC SEIZURE; WOLF HIRSCHHORN SYNDROME;

ABNORMALITIES, MULTIPLE; ADOLESCENT; BROMIDES; CHILD; CHILD, PRESCHOOL; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 4; ELECTROENCEPHALOGRAPHY; EPILEPSY; FACIES; FEMALE; HUMANS; JAPAN; MALE; SODIUM COMPOUNDS; STATUS EPILEPTICUS; TRANSLOCATION, GENETIC;

EID: 13144252159     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0013-9580.2005.02804.x     Document Type: Review

References (15)

1. Hirschhorn K, Cooper HL, Firschein IL. Deletion of short arms of chromosome 4-5 in a child with defects of midline fusion. Humangenetik 1965;1:479-482.
2. Lurie IW, Lazjuk GI, Ussova YI, et al. The Wolf-Hirschhorn syndrome, I: genetics. Clin Genet 1980;17:375-384.
3. Wright TJ, Ricke DO, Denison K, et al. A transcript map of the newly defined 165 kb Wolf-Hirschhorn syndrome critical region. Hum Mol Genet 1997;6:317-324.
4. Neu RL, Shott RJ, Gardner LI. 4p- phenotype in an infant with t (4p-; 19p or q+) mat translocation. Am J Dis Child 1975;129:363-365.
5. Kanazawa O, Irie N, Kawai I. Epileptic seizures in the 4p- syndrome: Report of two cases. Jpn J Psychiatry Neurol 1991;45:653-659.
6. Battaglia D, Zampino G, Zollino M, et al. Electroclinical patterns and evolution of epilepsy in the 4p- syndrome. Epilepsia 2003;44:1183-90.
7. Battaglia A, Carey JC, Cederholm P, et al. Natural history of Wolf-Hirschhorn syndrome: experience with 15 cases. Pediatrics 1999;103:830-6.
8. Battaglia A, Carey JC, Wright TJ. Wolf-Hirschhorn (4p-) syndrome. Adv Pediatr 2001;48:75-113.
9. Sgro V, Riva E, Canevini MP, et al. 4p(-) syndrome: A chromosomal disorder associated with a particular EEG pattern. Epilepsia 1995;36:1206-1214.
10. Ernst JP, Doose H, Baier WK. Bromides were effective in intractable epilepsy with generalized tonic-clonic seizures and onset in early childhood. Brain Dev 1998;10:385-388.
11. Oguni H, Hayashi K, Oguni M, et al. Treatment of severe myoclonic epilepsy in infants with bromide and its borderline variant. Epilepsia 1994;35:1140-1145.
12. Browne TR, Ascanape JS. Diones, Paraldehyde, Phenacemide, Bromides, and Sulthiame. In: Engel J, Pedley TA, eds. Epilepsia: a comprehensive textbook. Philadelphia: Lippincott-Raven, 1998:1634-44.
13. Claes L, Del-Favero J, Ceulemans B, et al: De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. Am J Hum Genet 2001;68:1327-32.
14. Endele S, Fuhry M, Pak SJ, et al. LETM1, a novel gene encoding a putative EF-hand Ca(2+)-binding protein, flanks the Wolf-Hirschhorn syndrome (WHS) critical region and is deleted in most WHS patients. Genomics 1999;60:218-225.
15. Meierkord H, Grunig F, Gutschmidt U, et al. Sodium bromide: effects on different patterns of epileptiform activity, extracellular pH changes and GABAergic inhibition. Naunyn Schmiedebergs Arch Pharmacol 2000;361:25-32.